1
|
Kromhout MA, Rius Ottenheim N, Putter H, Numans ME, Achterberg WP. Caffeine Consumption and Behavioral Symptoms in Nursing Home Residents: A Cross-Sectional Analysis. J Nutr Health Aging 2021; 25:100-107. [PMID: 33367469 DOI: 10.1007/s12603-020-1436-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE Although behavioral changes are common in nursing home residents with dementia and caffeine is known to influence behavior in healthy adults, the effects of caffeine on the behavior of persons with dementia has received little attention. In this study we assessed the relationship of caffeine and behavioral symptoms in older persons with dementia. DESIGN A multicenter sub-cohort study embedded in the Elderly Care Physicians (ECP) training program. SETTING Dutch nursing homes associated with the ECP training program. PARTICIPANTS A total of 206 individuals with both diabetes and dementia resident in Dutch nursing homes. MEASUREMENTS Trainee ECPs collected data on caffeine consumption, cognition and behavioral symptoms using the NPI-NH, MDS-DRS and AES-C. Data on factors known to influence behavior in persons with dementia (e.g. marital status, kidney function, urinary tract infection and medication) were also collected. RESULTS Of the 206 participants, 70% showed behavioral symptoms. An increase in caffeine consumption was associated with a decrease in the presence of behavioral symptoms in the NPI-NH cluster affect and NPI-NH item agitation. Caffeine consumption groups also differed on the presence of disinhibition and depression. In addition, the severity of dementia influenced agitation, anxiety and the clusters affect and psychomotor. CONCLUSION In a large group of older persons with dementia resident in nursing homes, a low daily consumption of caffeine was associated with greater behavioral symptoms.
Collapse
Affiliation(s)
- M A Kromhout
- M.A. Kromhout (Michelle) MD, Leiden University Medical Centre, Department of Public health and Primary Care, V0-P, Postbus 9600, 2300 RC Leiden, The Netherlands,
| | | | | | | | | |
Collapse
|
2
|
Kromhout MA, Rius Ottenheim N, Giltay E, Numans ME, Achterberg WP. Caffeine and neuropsychiatric symptoms in patients with dementia: A systematic review. Exp Gerontol 2019; 122:85-91. [PMID: 31051199 DOI: 10.1016/j.exger.2019.04.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Revised: 04/26/2019] [Accepted: 04/27/2019] [Indexed: 10/26/2022]
Abstract
BACKGROUND The consumption of caffeine has well known effects on the behavior and sleep of healthy adults. Behavioral symptoms and sleeping difficulties are common in patients with dementia which may be affected by caffeine consumption. This systematic review examines the association between caffeine intake and neuropsychiatric symptoms in patients with dementia. METHODS In January 2019 an extensive search was conducted in Medline (PubMed), Embase, Emcare, Cochrane, PsychInfo, Web of Science and gray literature. Studies were included when they: i) investigated patients diagnosed with dementia, ii) reported neuropsychiatric symptoms, iii) used caffeine or coffee consumption as an intervention, and iv) reported associations between caffeine or coffee consumption and neuropsychiatric symptoms. Studies were excluded when they also included participants without a diagnosis of dementia, or presented a review or expert opinion. Two reviewers independently rated the studies and reached consensus on the appraisal. RESULTS Of the seven studies eligible for this review, four reported on sleeping difficulties and five on behavioral symptoms. There was no consistent effect of caffeine administration on neuropsychiatric symptoms: e.g., both high caffeine consumption and eliminating caffeine were associated with less apathy, the total Neuropsychiatric Inventory (Nursing Home) decreased after both coffee therapy and after eliminating caffeine, and both caffeine consumption and eliminating caffeine improved sleep. CONCLUSION These findings suggest that caffeine can either induce or reduce neuropsychiatric symptoms in individual patients with dementia. Therefore, in these patients, caffeine consumption requires a prudent individualized approach and further research on the effects of caffeine on individual neuropsychiatric symptoms is required.
Collapse
Affiliation(s)
- M A Kromhout
- Leiden University Medical Centre, department of Public Health and Primary Care, V0-P, Postbus 9600, 2300 RC Leiden, the Netherlands.
| | - N Rius Ottenheim
- Leiden University Medical Centre, department of Psychiatry, B1-P, Postbus 9600, 2300 RC, Leiden, the Netherlands
| | - E Giltay
- Leiden University Medical Centre, department of Psychiatry, B1-P, Postbus 9600, 2300 RC, Leiden, the Netherlands
| | - M E Numans
- Leiden University Medical Centre, department of Public Health and Primary Care, V0-P, Postbus 9600, 2300 RC Leiden, the Netherlands
| | - W P Achterberg
- Leiden University Medical Centre, department of Public Health and Primary Care, V0-P, Postbus 9600, 2300 RC Leiden, the Netherlands
| |
Collapse
|
3
|
[Single pathogenesis of geriatric syndrome]. Nihon Ronen Igakkai Zasshi 2018; 55:301-310. [PMID: 30122694 DOI: 10.3143/geriatrics.55.301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
|
4
|
Fujii M, Sasaki H. [Is dementia a treatable disease?]. Nihon Ronen Igakkai Zasshi 2017; 54:114-118. [PMID: 28592729 DOI: 10.3143/geriatrics.54.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
|
5
|
Núñez C, Stephan-Otto C, Cuevas-Esteban J, Maria Haro J, Huerta-Ramos E, Ochoa S, Usall J, Brébion G. Effects of caffeine intake and smoking on neurocognition in schizophrenia. Psychiatry Res 2015; 230:924-31. [PMID: 26614014 DOI: 10.1016/j.psychres.2015.11.022] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/03/2015] [Revised: 10/30/2015] [Accepted: 11/15/2015] [Indexed: 02/09/2023]
Abstract
Although most studies support the beneficial effects of caffeine on neurocognition, its effects have never been assessed in psychiatric patients. In addition, results from studies in smokers are contradictory. Moreover, there are no data available about the neurocognitive effects of caffeine and tobacco together. We explored the concomitant effects of regular caffeine and tobacco intake on neurocognition in 52 schizophrenic patients and 61 healthy controls. Verbal fluency, processing speed, and working, visual and verbal memory were assessed. For each measurement, two tasks with two levels of complexity were administered. Our results showed that caffeine intake had beneficial effects on male schizophrenic patients only in complex tasks requiring deeper cognitive processing (semantic fluency, cognitive speed, working memory, and visual memory). Female patients and controls were unaffected. In contrast, smoking had a negative effect on male, but not on female, schizophrenic patients in semantic fluency. The effects of smoking in controls were inconsistent. In conclusion, our data showed, for the first time, beneficial effects of caffeine intake on neurocognition in male schizophrenic patients. These data suggest that further research of therapeutics based on caffeine is needed, as this could be beneficial for schizophrenic patients. In contrast, smoking appears to be detrimental.
Collapse
Affiliation(s)
- Christian Núñez
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat (Barcelona), C/Doctor Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain.
| | - Christian Stephan-Otto
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat (Barcelona), C/Doctor Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain
| | - Jorge Cuevas-Esteban
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat (Barcelona), C/Doctor Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain
| | - Josep Maria Haro
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat (Barcelona), C/Doctor Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain
| | - Elena Huerta-Ramos
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat (Barcelona), C/Doctor Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain
| | - Susana Ochoa
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat (Barcelona), C/Doctor Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain
| | - Judith Usall
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat (Barcelona), C/Doctor Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain
| | - Gildas Brébion
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat (Barcelona), C/Doctor Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain
| |
Collapse
|
6
|
Affiliation(s)
| | - James P Butler
- Division of Sleep Medicine, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA
| | | |
Collapse
|
7
|
Mariko A, Matsuda H, Takahashi M, Fujii M, Sasaki H. Touch on the acupoint of Shinchuu of Alzheimer's disease patients. Geriatr Gerontol Int 2015; 15:385-6. [DOI: 10.1111/ggi.12351] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Fujii M, Ishizuka S, Sasaki H. Small Group Teaching in a psychiatric hospital for dementia patients. Geriatr Gerontol Int 2015; 15:239-40. [DOI: 10.1111/ggi.12370] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Fujii M, Butler JP, Sasaki H. Emotional function in dementia patients. Psychogeriatrics 2014; 14:202-9. [PMID: 25250479 DOI: 10.1111/psyg.12059] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2014] [Accepted: 07/29/2014] [Indexed: 11/28/2022]
Abstract
Behavioural and psychological symptoms of dementia, which can be considered as hyperreactivity of the emotional functioning of dementia, can be alleviated or aggravated by the behavioural and psychological symptoms of the caregiver. Comfortable stimulations of emotional function through sensory stimulations are effective methods for alleviating behavioural and psychological symptoms of dementia. Although cognitive function deteriorates with age, emotional function is often retained even in advanced years. Thus, it is recommended that care in patients with dementia be focused mainly on the stimulation of emotional function (e.g. sympathy and empathy, which are human traits), rather than relying solely on the stimulation of cognitive function.
Collapse
|
10
|
Kaneko Y, Butler JP, Saitoh E, Horie T, Fujii M, Sasaki H. Efficacy of white noise therapy for dementia patients with schizophrenia. Geriatr Gerontol Int 2013; 13:808-10. [DOI: 10.1111/ggi.12028] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
| | - James P. Butler
- Division of Sleep Medicine; Department of Medicine; Harvard Medical School; Brigham and Women's Hospital; Boston; USA
| | | | | | | | | |
Collapse
|
11
|
Satoh S, Kajiwara M, Kiyokawa E, Toukairin Y, Fujii M, Sasaki H. Rivastigmine patch and massage for Alzheimer's disease patients. Geriatr Gerontol Int 2013; 13:515-6. [DOI: 10.1111/ggi.12010] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Sachiko Satoh
- Yamagata Kousei Hospital; Sendai Tomizawa Hospital; Yamagata; Sendai; Japan
| | - Mutsuko Kajiwara
- Yamagata Kousei Hospital; Sendai Tomizawa Hospital; Yamagata; Sendai; Japan
| | - Emi Kiyokawa
- Yamagata Kousei Hospital; Sendai Tomizawa Hospital; Yamagata; Sendai; Japan
| | - Yoshiko Toukairin
- Yamagata Kousei Hospital; Sendai Tomizawa Hospital; Yamagata; Sendai; Japan
| | - Masahiko Fujii
- Yamagata Kousei Hospital; Sendai Tomizawa Hospital; Yamagata; Sendai; Japan
| | - Hidetada Sasaki
- Yamagata Kousei Hospital; Sendai Tomizawa Hospital; Yamagata; Sendai; Japan
| |
Collapse
|
12
|
|
13
|
P. Butler J, Fujii M, Sasaki H. New Lessons of Nurturing Life for Geriatric Patients. TOHOKU J EXP MED 2012; 227:203-10. [DOI: 10.1620/tjem.227.203] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Affiliation(s)
- James P. Butler
- Division of Sleep Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital
- Department of Environmental Health, Harvard School of Public Health
| | | | | |
Collapse
|